ID   VAMP2_RAT               Reviewed;         116 AA.
AC   P63045; Q64357;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 178.
DE   RecName: Full=Vesicle-associated membrane protein 2;
DE            Short=VAMP-2;
DE   AltName: Full=Synaptobrevin-2;
GN   Name=Vamp2; Synonyms=Syb2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=2472388; DOI=10.1016/s0021-9258(18)60426-0;
RA   Elferink L.A., Trimble W.S., Scheller R.H.;
RT   "Two vesicle-associated membrane protein genes are differentially expressed
RT   in the rat central nervous system.";
RL   J. Biol. Chem. 264:11061-11064(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 32-47 AND 60-83, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 33-86, AND PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)
RP   BY C.BOTULINUM NEUROTOXIN TYPE X.
RX   PubMed=28770820; DOI=10.1038/ncomms14130;
RA   Zhang S., Masuyer G., Zhang J., Shen Y., Lundin D., Henriksson L.,
RA   Miyashita S.I., Martinez-Carranza M., Dong M., Stenmark P.;
RT   "Identification and characterization of a novel botulinum neurotoxin.";
RL   Nat. Commun. 8:14130-14130(2017).
RN   [5]
RP   PROTEIN SEQUENCE OF 77-101, POSSIBLE FUNCTION, AND PROTEOLYTIC CLEAVAGE
RP   (MICROBIAL INFECTION) BY C.BOTULINUM NEUROTOXIN TYPE B AND BY C.TETANI
RP   TETANUS TOXIN.
RX   PubMed=1331807; DOI=10.1038/359832a0;
RA   Schiavo G., Benfenati F., Poulain B., Rossetto O., de Laureto P.P.,
RA   Dasgupta B.R., Montecucco C.;
RT   "Tetanus and botulinum-B neurotoxins block neurotransmitter release by
RT   proteolytic cleavage of synaptobrevin.";
RL   Nature 359:832-835(1992).
RN   [6]
RP   PROTEIN SEQUENCE OF 59-82, AND PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)
RP   BY C.BOTULINUM NEUROTOXIN TYPE F.
RX   PubMed=8505288; DOI=10.1016/s0021-9258(19)50230-7;
RA   Schiavo G., Shone C.C., Rossetto O., Alexander F.C., Montecucco C.;
RT   "Botulinum neurotoxin serotype F is a zinc endopeptidase specific for
RT   VAMP/synaptobrevin.";
RL   J. Biol. Chem. 268:11516-11519(1993).
RN   [7]
RP   PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY C.BOTULINUM NEUROTOXIN TYPE
RP   G.
RX   PubMed=7910017; DOI=10.1006/bbrc.1994.1526;
RA   Yamasaki S., Binz T., Hayashi T., Szabo E., Yamasaki N., Eklund M.,
RA   Jahn R., Niemann H.;
RT   "Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat
RT   synaptobrevin 2.";
RL   Biochem. Biophys. Res. Commun. 200:829-835(1994).
RN   [8]
RP   PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY C.BOTULINUM NEUROTOXIN TYPES
RP   D AND F AND BY C.TETANI TETANUS TOXIN.
RX   PubMed=8175689; DOI=10.1016/s0021-9258(18)99941-2;
RA   Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F.,
RA   Roques B., Fykse E.M., Suedhof T.C., Jahn R., Niemann H.;
RT   "Cleavage of members of the synaptobrevin/VAMP family by types D and F
RT   botulinal neurotoxins and tetanus toxin.";
RL   J. Biol. Chem. 269:12764-12772(1994).
RN   [9]
RP   FUNCTION, INTERACTION WITH KCNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=19690160; DOI=10.1074/jbc.m109.028761;
RA   Lvov A., Greitzer D., Berlin S., Chikvashvili D., Tsuk S., Lotan I.,
RA   Michaelevski I.;
RT   "Rearrangements in the relative orientation of cytoplasmic domains induced
RT   by a membrane-anchored protein mediate modulations in Kv channel gating.";
RL   J. Biol. Chem. 284:28276-28291(2009).
RN   [10]
RP   INTERACTION WITH SEPT8; SYP; SNAP25 AND STX1A, AND TISSUE SPECIFICITY.
RX   PubMed=19196426; DOI=10.1111/j.1471-4159.2008.05849.x;
RA   Ito H., Atsuzawa K., Morishita R., Usuda N., Sudo K., Iwamoto I.,
RA   Mizutani K., Katoh-Semba R., Nozawa Y., Asano T., Nagata K.;
RT   "Sept8 controls the binding of vesicle-associated membrane protein 2 to
RT   synaptophysin.";
RL   J. Neurochem. 108:867-880(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-97 IN COMPLEX WITH STX1A AND
RP   SNAP25.
RX   PubMed=9759724; DOI=10.1038/26412;
RA   Sutton R.B., Fasshauer D., Jahn R., Brunger A.T.;
RT   "Crystal structure of a SNARE complex involved in synaptic exocytosis at
RT   2.4 A resolution.";
RL   Nature 395:347-353(1998).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 30-94 IN COMPLEX WITH STX1A; CPLX1
RP   AND SNAP25, AND STRUCTURE BY NMR.
RX   PubMed=11832227; DOI=10.1016/s0896-6273(02)00583-4;
RA   Chen X., Tomchick D.R., Kovrigin E., Arac D., Machius M., Suedhof T.C.,
RA   Rizo J.;
RT   "Three-dimensional structure of the complexin/SNARE complex.";
RL   Neuron 33:397-409(2002).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 29-90 IN COMPLEX WITH STX1A AND
RP   SNAP25.
RX   PubMed=12496247; DOI=10.1074/jbc.m211889200;
RA   Ernst J.A., Brunger A.T.;
RT   "High resolution structure, stability, and synaptotagmin binding of a
RT   truncated neuronal SNARE complex.";
RL   J. Biol. Chem. 278:8630-8636(2003).
CC   -!- FUNCTION: Involved in the targeting and/or fusion of transport vesicles
CC       to their target membrane (By similarity). Major SNARE protein of
CC       synaptic vesicles which mediates fusion of synaptic vesicles to release
CC       neurotransmitters. Essential for fast vesicular exocytosis and
CC       activity-dependent neurotransmitter release as well as fast endocytosis
CC       that mediates rapid reuse of synaptic vesicles (Probable). Modulates
CC       the gating characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1 (PubMed:19690160).
CC       {ECO:0000250|UniProtKB:P63044, ECO:0000269|PubMed:19690160,
CC       ECO:0000305|PubMed:1331807}.
CC   -!- SUBUNIT: Part of the SNARE core complex containing SNAP25, VAMP2 and
CC       STX1A; this complex constitutes the basic catalytic machinery of the
CC       complex neurotransmitter release apparatus (PubMed:19196426). Recruited
CC       to the SNARE complex following binding of the SNARE complex component
CC       STX1A to STXBP1 (By similarity). This complex binds to CPLX1. Interacts
CC       with BVES and STX4. Interacts with VAPA and VAPB. Interacts with WDFY2,
CC       PRKCZ and PRKCI (By similarity). Interacts (via N-terminus) with KCNB1
CC       (via N-terminus and C-terminus); stimulates the channel inactivation
CC       rate of KCNB1 (PubMed:19690160). Forms a complex with WDFY2 and PRKCZ
CC       (By similarity). Interacts with SEPT8; the interaction inhibits
CC       interaction of VAMP2 with SYP (PubMed:19196426). Interacts with SYP;
CC       the interaction is inhibited by interaction with SEPT8
CC       (PubMed:19196426). Interacts with PICALM (By similarity). Interacts
CC       with alpha-synuclein/SNCA (By similarity). Interacts with STX3 (By
CC       similarity). {ECO:0000250|UniProtKB:P63027,
CC       ECO:0000250|UniProtKB:P63044, ECO:0000269|PubMed:19196426,
CC       ECO:0000269|PubMed:19690160}.
CC   -!- INTERACTION:
CC       P63045; D4A229: Prkd3; NbExp=2; IntAct=EBI-520880, EBI-1255458;
CC       P63045; P60881-2: Snap25; NbExp=4; IntAct=EBI-520880, EBI-15685612;
CC       P63045; P32851: Stx1a; NbExp=8; IntAct=EBI-520880, EBI-539720;
CC       P63045; Q08850: Stx4; NbExp=8; IntAct=EBI-520880, EBI-918243;
CC       P63045; P21707: Syt1; NbExp=7; IntAct=EBI-520880, EBI-458098;
CC       P63045; P63045: Vamp2; NbExp=2; IntAct=EBI-520880, EBI-520880;
CC       P63045; Q60770: Stxbp3; Xeno; NbExp=2; IntAct=EBI-520880, EBI-8430169;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle membrane {ECO:0000250|UniProtKB:P63027}; Single-pass type IV
CC       membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:19690160}. Note=Colocalizes with PRKCZ and WDFY2 in
CC       intracellular vesicles. {ECO:0000250|UniProtKB:P63027}.
CC   -!- TISSUE SPECIFICITY: Nervous system specific. A higher level expression
CC       is seen in the brain as compared to the spinal cord (PubMed:2472388).
CC       Expressed in hippocampal neurons (PubMed:19196426).
CC       {ECO:0000269|PubMed:19196426, ECO:0000269|PubMed:2472388}.
CC   -!- PTM: Phosphorylated by PRKCZ in vitro and this phosphorylation is
CC       increased in the presence of WDFY2. {ECO:0000250|UniProtKB:P63027}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type B (BoNT/B, botB) which hydrolyzes the 76-Gln-|-Phe-77
CC       bond and inhibits neurotransmitter release (PubMed:1331807).
CC       {ECO:0000269|PubMed:1331807}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type D (BoNT/D, botD) which hydrolyzes the 59-Lys-|-Leu-60
CC       bond and inhibits neurotransmitter release (PubMed:8175689).
CC       {ECO:0000269|PubMed:8175689}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type F (BoNT/F, botF) which hydrolyzes the 58-Gln-|-Lys-59
CC       bond and probably inhibits neurotransmitter release (PubMed:8505288).
CC       {ECO:0000269|PubMed:8505288, ECO:0000305|PubMed:8175689}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type G (BoNT/G, botG) which hydrolyzes the 81-Ala-|-Ala-82
CC       bond and probably inhibits neurotransmitter release (PubMed:8505288).
CC       {ECO:0000269|PubMed:7910017}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type X (BoNT/X) which hydrolyzes the 66-Arg-|-Ala-67 bond
CC       and probably inhibits neurotransmitter release (PubMed:28770820). It
CC       remains unknown whether BoNT/X is ever produced, or what organisms it
CC       targets. {ECO:0000269|PubMed:28770820}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.tetani toxin
CC       (tetX) which hydrolyzes the 76-Gln-|-Phe-77 bond and inhibits
CC       neurotransmitter release (PubMed:1331807). {ECO:0000269|PubMed:1331807,
CC       ECO:0000305|PubMed:8175689}.
CC   -!- SIMILARITY: Belongs to the synaptobrevin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M24105; AAA42321.1; -; mRNA.
DR   EMBL; BC074003; AAH74003.1; -; mRNA.
DR   PIR; B34288; B34288.
DR   RefSeq; NP_036795.1; NM_012663.2.
DR   PDB; 1KIL; X-ray; 2.30 A; A=28-92.
DR   PDB; 1N7S; X-ray; 1.45 A; A=28-88.
DR   PDB; 1SFC; X-ray; 2.40 A; A/E/I=1-96.
DR   PDB; 2KOG; NMR; -; A=1-116.
DR   PDB; 2N1T; NMR; -; A=25-93.
DR   PDB; 3HD7; X-ray; 3.40 A; A/E=30-116.
DR   PDB; 3IPD; X-ray; 4.80 A; A/E=30-116.
DR   PDB; 3J96; EM; 7.60 A; K=28-89.
DR   PDB; 3J97; EM; 7.80 A; K=28-89.
DR   PDB; 3J98; EM; 8.40 A; K=28-89.
DR   PDB; 3J99; EM; 8.20 A; K=28-89.
DR   PDB; 5CCG; X-ray; 3.50 A; A/G=28-89.
DR   PDB; 5CCH; X-ray; 3.60 A; A=28-89.
DR   PDB; 5CCI; X-ray; 4.10 A; A=28-89.
DR   PDB; 5W5C; X-ray; 1.85 A; A=28-66.
DR   PDB; 5W5D; X-ray; 2.50 A; A=28-66.
DR   PDB; 6A30; X-ray; 2.79 A; P=87-92.
DR   PDB; 6IP1; EM; 3.90 A; A=1-94.
DR   PDB; 6MDM; EM; 4.40 A; J=1-89.
DR   PDB; 6MDN; EM; 4.40 A; J=1-72.
DR   PDB; 6MTI; EM; 10.40 A; A/E/I/M/Q/U=28-89.
DR   PDB; 6WVW; X-ray; 2.11 A; A/E=28-89.
DR   PDB; 7UDB; EM; 3.50 A; C=29-83.
DR   PDBsum; 1KIL; -.
DR   PDBsum; 1N7S; -.
DR   PDBsum; 1SFC; -.
DR   PDBsum; 2KOG; -.
DR   PDBsum; 2N1T; -.
DR   PDBsum; 3HD7; -.
DR   PDBsum; 3IPD; -.
DR   PDBsum; 3J96; -.
DR   PDBsum; 3J97; -.
DR   PDBsum; 3J98; -.
DR   PDBsum; 3J99; -.
DR   PDBsum; 5CCG; -.
DR   PDBsum; 5CCH; -.
DR   PDBsum; 5CCI; -.
DR   PDBsum; 5W5C; -.
DR   PDBsum; 5W5D; -.
DR   PDBsum; 6A30; -.
DR   PDBsum; 6IP1; -.
DR   PDBsum; 6MDM; -.
DR   PDBsum; 6MDN; -.
DR   PDBsum; 6MTI; -.
DR   PDBsum; 6WVW; -.
DR   PDBsum; 7UDB; -.
DR   AlphaFoldDB; P63045; -.
DR   BMRB; P63045; -.
DR   EMDB; EMD-26455; -.
DR   EMDB; EMD-6206; -.
DR   EMDB; EMD-6207; -.
DR   EMDB; EMD-6208; -.
DR   EMDB; EMD-6209; -.
DR   EMDB; EMD-9100; -.
DR   EMDB; EMD-9101; -.
DR   EMDB; EMD-9697; -.
DR   SMR; P63045; -.
DR   BioGRID; 246926; 6.
DR   CORUM; P63045; -.
DR   DIP; DIP-35503N; -.
DR   IntAct; P63045; 25.
DR   MINT; P63045; -.
DR   STRING; 10116.ENSRNOP00000054114; -.
DR   iPTMnet; P63045; -.
DR   PhosphoSitePlus; P63045; -.
DR   SwissPalm; P63045; -.
DR   jPOST; P63045; -.
DR   PaxDb; 10116-ENSRNOP00000054114; -.
DR   Ensembl; ENSRNOT00000057295.4; ENSRNOP00000054114.4; ENSRNOG00000006989.8.
DR   Ensembl; ENSRNOT00055055905; ENSRNOP00055046063; ENSRNOG00055032376.
DR   Ensembl; ENSRNOT00060052392; ENSRNOP00060043611; ENSRNOG00060030134.
DR   Ensembl; ENSRNOT00065044713; ENSRNOP00065036613; ENSRNOG00065025916.
DR   GeneID; 24803; -.
DR   KEGG; rno:24803; -.
DR   UCSC; RGD:3949; rat.
DR   AGR; RGD:3949; -.
DR   CTD; 6844; -.
DR   RGD; 3949; Vamp2.
DR   eggNOG; KOG0860; Eukaryota.
DR   GeneTree; ENSGT00940000158370; -.
DR   HOGENOM; CLU_064620_4_0_1; -.
DR   InParanoid; P63045; -.
DR   OrthoDB; 4846040at2759; -.
DR   PhylomeDB; P63045; -.
DR   Reactome; R-RNO-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-199992; trans-Golgi Network Vesicle Budding.
DR   Reactome; R-RNO-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-RNO-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-RNO-449836; Other interleukin signaling.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-888590; GABA synthesis, release, reuptake and degradation.
DR   Reactome; R-RNO-9609523; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane.
DR   EvolutionaryTrace; P63045; -.
DR   PRO; PR:P63045; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000006989; Expressed in frontal cortex and 20 other cell types or tissues.
DR   GO; GO:0030136; C:clathrin-coated vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0044306; C:neuron projection terminus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0030141; C:secretory granule; IDA:UniProtKB.
DR   GO; GO:0031201; C:SNARE complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000322; C:storage vacuole; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0070044; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; IDA:MGI.
DR   GO; GO:0070032; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; IDA:MGI.
DR   GO; GO:0070033; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0005802; C:trans-Golgi network; ISO:RGD.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0042589; C:zymogen granule membrane; ISO:RGD.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008289; F:lipid binding; EXP:DisProt.
DR   GO; GO:0060090; F:molecular adaptor activity; EXP:DisProt.
DR   GO; GO:0017022; F:myosin binding; IPI:RGD.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005484; F:SNAP receptor activity; IBA:GO_Central.
DR   GO; GO:0000149; F:SNARE binding; IDA:MGI.
DR   GO; GO:0019905; F:syntaxin binding; ISO:RGD.
DR   GO; GO:0017075; F:syntaxin-1 binding; IDA:MGI.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:UniProtKB.
DR   GO; GO:0017156; P:calcium-ion regulated exocytosis; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.
DR   GO; GO:0043308; P:eosinophil degranulation; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0098967; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; IMP:SynGO.
DR   GO; GO:0043001; P:Golgi to plasma membrane protein transport; ISO:RGD.
DR   GO; GO:0046879; P:hormone secretion; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0061025; P:membrane fusion; ISO:RGD.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:0045055; P:regulated exocytosis; ISO:RGD.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0017157; P:regulation of exocytosis; IMP:RGD.
DR   GO; GO:1903421; P:regulation of synaptic vesicle recycling; IMP:RGD.
DR   GO; GO:0060627; P:regulation of vesicle-mediated transport; ISO:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:UniProtKB.
DR   GO; GO:0035493; P:SNARE complex assembly; IMP:CAFA.
DR   GO; GO:0016081; P:synaptic vesicle docking; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0006906; P:vesicle fusion; ISS:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; IMP:RGD.
DR   GO; GO:0099003; P:vesicle-mediated transport in synapse; ISO:RGD.
DR   CDD; cd15870; R-SNARE_VAMP2; 1.
DR   DisProt; DP00622; -.
DR   Gene3D; 1.20.5.110; -; 1.
DR   InterPro; IPR001388; Synaptobrevin-like.
DR   InterPro; IPR016444; Synaptobrevin/VAMP.
DR   InterPro; IPR042855; V_SNARE_CC.
DR   PANTHER; PTHR45701; SYNAPTOBREVIN FAMILY MEMBER; 1.
DR   PANTHER; PTHR45701:SF5; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; 1.
DR   Pfam; PF00957; Synaptobrevin; 1.
DR   PIRSF; PIRSF005409; Synaptobrevin_euk; 1.
DR   PRINTS; PR00219; SYNAPTOBREVN.
DR   SUPFAM; SSF58038; SNARE fusion complex; 1.
DR   PROSITE; PS00417; SYNAPTOBREVIN; 1.
DR   PROSITE; PS50892; V_SNARE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Coiled coil; Cytoplasmic vesicle;
KW   Direct protein sequencing; Membrane; Phosphoprotein; Reference proteome;
KW   Synapse; Transmembrane; Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P63026"
FT   CHAIN           2..116
FT                   /note="Vesicle-associated membrane protein 2"
FT                   /id="PRO_0000206726"
FT   TOPO_DOM        2..94
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        95..114
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        115..116
FT                   /note="Vesicular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..91
FT                   /note="v-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00290"
FT   REGION          1..28
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          92..116
FT                   /note="Required for interaction with SEPT8"
FT                   /evidence="ECO:0000269|PubMed:19196426"
FT   SITE            58..59
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type F (BoNT/F, botF)"
FT                   /evidence="ECO:0000269|PubMed:8505288"
FT   SITE            59..60
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type D (BoNT/D, botD)"
FT                   /evidence="ECO:0000269|PubMed:8175689"
FT   SITE            66..67
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type X (BoNT/X)"
FT                   /evidence="ECO:0000269|PubMed:28770820"
FT   SITE            76..77
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type B (BoNT/B, botB)"
FT                   /evidence="ECO:0000269|PubMed:1331807"
FT   SITE            76..77
FT                   /note="(Microbial infection) Cleavage; by C.tetani tetanus
FT                   toxin (tetX)"
FT                   /evidence="ECO:0000269|PubMed:1331807"
FT   SITE            81..82
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type G (BoNT/G, botG)"
FT                   /evidence="ECO:0000269|PubMed:7910017"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63026"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:2KOG"
FT   HELIX           29..88
FT                   /evidence="ECO:0007829|PDB:1N7S"
FT   HELIX           91..115
FT                   /evidence="ECO:0007829|PDB:2KOG"
SQ   SEQUENCE   116 AA;  12691 MW;  4A0D0D56B5409D0A CRC64;
     MSATAATVPP AAPAGEGGPP APPPNLTSNR RLQQTQAQVD EVVDIMRVNV DKVLERDQKL
     SELDDRADAL QAGASQFETS AAKLKRKYWW KNLKMMIILG VICAIILIII IVYFST
//
